Persistent Pertussis

An altered vaccine and parents opting-out of inoculations have contributed to ongoing outbreaks across the U.S.

Written byJyoti Madhusoodanan
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

CDCAmid new teachers and first homework assignments, the start of the school year often brings sniffles, coughs, and other signs of infectious diseases. In some parts of the U.S., going back to school can also mean a greater risk of students coming down with vaccine-preventable illnesses. In California, for example, the parents of approximately 3 percent of children opted out of having their kids vaccinated on the basis of their personal beliefs this year, according to the state’s Department of Public Health. This state-wide opt-out rate has nearly doubled in recent years, KQED’s State of Health blog reported this month (September 11).

The proportion of unvaccinated children in California schools varies by county, with some reporting opt-out rates as high as 7.5 percent. As these numbers increase, herd immunity—a population’s ability to prevent disease transmission because the majority of people are inoculated—begins to collapse, raising the risk of preventable infections such as measles and pertussis, also known as whooping cough.

In its most recent tally of California’s continuing whooping cough epidemic, the US Centers for Disease Control and Prevention (CDC) reported nearly 8,000 cases of pertussis in the state this year; 267 of those cases were severe enough to require hospitalization.

And it’s not just California that’s seen a recent surge in pertussis: several Washington, DC-area schools reported more than a dozen cases just last week. Minnesota ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies